A Study for Leukemia Patients With Life-Threatening Infections
NCT00968838 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 178
Last updated 2013-11-26
Summary
The goal of this clinical research study is to compare the effectiveness of a white blood cell transfusion with radiated cells to a white blood cell transfusion with cells that have not been radiated. The safety of this procedure will also be studied.
Conditions
Interventions
- PROCEDURE
-
White Blood Cell Transfusion
4 Transfusions, each taking approximately 1 hour: Patients \<50 years of age receive 4 standard transfusions before they are randomized to receive further radiated or non radiated transfusions. Patients \>50 years of age are randomized to receive either radiated or non radiated transfusions.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Emil J Freireich, MD, BS · UT MD Anderson Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2011-08-31
- Completion
- 2011-08-31
Countries
- United States
Study Locations
More Related Trials
-
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00005092 ·Status: COMPLETED ·Phase: PHASE1
-
Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States
NCT00038779 ·Status: TERMINATED ·Phase: NA
-
Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
NCT00423826 ·Status: NO_LONGER_AVAILABLE
-
Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant
NCT00068718 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Red Blood Cell Transfusion Thresholds and QOL in MDS
NCT02099669 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
NCT07285668 ·Status: SUSPENDED ·Phase: NA
-
Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma
NCT00024128 ·Status: WITHDRAWN ·Phase: PHASE2
-
Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells
NCT01362452 ·Status: COMPLETED ·Phase: PHASE1
-
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
NCT02991898 ·Status: TERMINATED ·Phase: PHASE2
-
T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
NCT01860937 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
NCT00376480 ·Status: COMPLETED ·Phase: PHASE1
-
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)
NCT00412360 ·Status: COMPLETED ·Phase: PHASE3
-
CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)
NCT01653717 ·Status: COMPLETED ·Phase: PHASE1
-
Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant
NCT00569283 ·Status: COMPLETED ·Phase: PHASE1
-
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease
NCT00719849 ·Status: TERMINATED ·Phase: PHASE2
-
Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies
NCT02333838 ·Status: UNKNOWN ·Phase: PHASE2
-
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
NCT00004878 ·Status: WITHDRAWN ·Phase: PHASE2
-
GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies
NCT00426205 ·Status: COMPLETED ·Phase: NA
-
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
NCT06859424 ·Status: RECRUITING ·Phase: PHASE2
-
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant
NCT00796068 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
NCT00630565 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
NCT00281879 ·Status: TERMINATED ·Phase: PHASE2
-
Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
NCT04262843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation
NCT00996359 ·Status: TERMINATED ·Phase: PHASE1
-
Randomized Double Cord Blood Transplant Study
NCT00067002 ·Status: COMPLETED ·Phase: PHASE2